Stocks
DermTech Financial Statements (DMTK) |
||||||||||
| DermTechsmart-lab.ru | % | 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 11.03.2020 | 05.03.2021 | 10.03.2022 | 02.03.2023 | 29.02.2024 | 29.02.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 3.36 | 5.89 | 11.8 | 14.5 | 15.3 | 15.3 | |||
| Operating Income, bln rub | -17.6 | -35.3 | -77.4 | -118.2 | -103.7 | -103.7 | ||||
| EBITDA, bln rub | ? | -18.0 | -35.3 | -76.3 | -118.3 | -97.9 | -99.6 | |||
| Net profit, bln rub | ? | -21.9 | -34.7 | -77.0 | -113.7 | -100.9 | -100.1 | |||
| OCF, bln rub | ? | -17.8 | -28.7 | -62.1 | -95.3 | -77.0 | -77.0 | |||
| CAPEX, bln rub | ? | 0.210 | 1.83 | 2.72 | 3.31 | 0.902 | 1.23 | |||
| FCF, bln rub | ? | -18.0 | -30.5 | -64.8 | -98.6 | -77.9 | -77.9 | |||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| OPEX, bln rub | 17.7 | 35.2 | 78.7 | 118.8 | 104.0 | 104.0 | ||||
| Cost of production, bln rub | 3.30 | 5.98 | 10.6 | 13.9 | 15.0 | 15.0 | ||||
| R&D, bln rub | 2.50 | 5.29 | 16.3 | 24.1 | 15.2 | 15.2 | ||||
| Interest expenses, bln rub | 2.66 | 0.040 | 0.000 | 1.34 | 0.000 | 1.55 | ||||
| Assets, bln rub | 18.2 | 69.8 | 248.3 | 202.1 | 121.9 | 121.9 | ||||
| Net Assets, bln rub | ? | 12.5 | 63.5 | 229.7 | 132.4 | 57.2 | 57.2 | |||
| Debt, bln rub | 0.000 | 0.335 | 7.86 | 55.8 | 54.4 | 54.4 | ||||
| Cash, bln rub | 15.4 | 63.8 | 225.3 | 126.2 | 55.9 | 55.9 | ||||
| Net debt, bln rub | -15.4 | -63.4 | -217.5 | -70.3 | -1.47 | -1.47 | ||||
| Ordinary share price, rub | 12.4 | 32.4 | 15.8 | 1.77 | 1.75 | 1.55 | ||||
| Number of ordinary shares, mln | 7.01 | 17.0 | 28.9 | 30.0 | 32.6 | 34.3 | ||||
| Market cap, bln rub | 87 | 551 | 456 | 53 | 57 | 53 | ||||
| EV, bln rub | ? | 71 | 487 | 239 | -17 | 56 | 52 | |||
| Book value, bln rub | 12 | 63 | 230 | 132 | 57 | 57 | ||||
| EPS, rub | ? | -3.13 | -2.05 | -2.66 | -3.79 | -3.09 | -2.92 | |||
| FCF/share, rub | -2.57 | -1.80 | -2.24 | -3.28 | -2.39 | -2.27 | ||||
| BV/share, rub | 1.78 | 3.74 | 7.95 | 4.41 | 1.75 | 1.67 | ||||
| EBITDA margin, % | ? | -533.9% | -599.6% | -644.6% | -814.9% | -640.0% | -651.0% | |||
| Net margin, % | ? | -651.1% | -590.0% | -650.2% | -783.3% | -659.6% | -654.5% | |||
| FCF yield, % | ? | -20.7% | -5.54% | -14.2% | -185.4% | -136.3% | -146.4% | |||
| ROE, % | ? | -175.4% | -54.7% | -33.5% | -85.9% | -176.5% | -175.1% | |||
| ROA, % | ? | -120.3% | -49.8% | -31.0% | -56.3% | -82.7% | -82.1% | |||
| P/E | ? | -3.97 | -15.9 | -5.93 | -0.47 | -0.57 | -0.53 | |||
| P/FCF | -4.83 | -18.0 | -7.04 | -0.54 | -0.73 | -0.68 | ||||
| P/S | ? | 25.8 | 93.6 | 38.6 | 3.66 | 3.73 | 3.48 | |||
| P/BV | ? | 6.96 | 8.68 | 1.99 | 0.40 | 1.00 | 0.93 | |||
| EV/EBITDA | ? | -3.98 | -13.8 | -3.13 | 0.15 | -0.57 | -0.52 | |||
| Debt/EBITDA | 0.86 | 1.80 | 2.85 | 0.59 | 0.02 | 0.01 | ||||
| R&D/CAPEX, % | 1 189% | 288.6% | 597.8% | 727.7% | 1 689% | 1 241% | ||||
| CAPEX/Revenue, % | 6.24% | 31.2% | 23.0% | 22.8% | 5.90% | 8.03% | ||||
| DermTech shareholders | ||||||||||
